GlassScriptPhysician profile
Jason A Efstathiou
NPI 1598967523
$156,002.55
in general payments reported to CMS, 2019-2025
20 companies · $26K in 2025
The $26K reported for 2025 was more than what 98% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37K · 2020: $15K · 2021: $1,100 · 2022: $26K · 2023: $45K · 2024: $5,933 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $53K · Honoraria: $11K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,625 · Travel and Lodging: $5,378 · Food and Beverage: $2,555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $52,515.00 |
| Honoraria | $11,073.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,625.00 |
| Travel and Lodging | $5,377.88 |
| Food and Beverage | $2,554.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $49,003.39 | 2019-2025 | Posluma |
| Boston Scientific Corporation | $30,036.55 | 2019-2025 | Spaceoar System, Spaceit Hydrogel System |
| Bioprotect Medical, INC. | $13,896.92 | 2024-2025 | Bioprotect Balloon Implant System |
| Progenics Pharmaceuticals, INC. | $9,357.29 | 2020-2023 | Pylarify |
| Pfizer INC. | $8,342.06 | 2022-2025 | |
| Astellas Pharma US INC | $6,442.19 | 2019-2023 | Xtandi |
| Myovant Sciences INC. | $6,305.00 | 2022 | |
| Genentech, INC. | $5,997.41 | 2020-2022 | |
| Angiodynamics, INC. | $5,609.62 | 2023 | Nanoknife |
| Iba Proton Therapy, INC. | $3,885.96 | 2023 | |
| Janssen Scientific Affairs, LLC | $3,200.00 | 2021-2022 | |
| Astrazeneca Uk Limited | $3,000.00 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $2,500.00 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,160.00 | 2022 | |
| Janssen Biotech, INC. | $2,115.00 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,935.15 | 2022 | |
| Elekta, INC. | $1,575.00 | 2023 | Mosaiq |
| Genentech USA, INC. | $534.58 | 2022-2024 | |
| Janssen Global Services, LLC | $73.09 | 2025 | Akeega |
| Varian Medical Systems, INC. | $33.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Efstathiou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.